News Releases

News Releases

Prometheus Biosciences to Host Virtual R&D Day for Investors on July 28, 2021

Jul 15, 2021
Featuring management and expert-led discussions on the science of TL1A, including the application and clinical trial approach of PRA023 in Inflammatory Bowel Disease SAN DIEGO, July 15, 2021 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company

Prometheus Biosciences Announces Upsized Pricing of Initial Public Offering

Mar 11, 2021
SAN DIEGO, March 11, 2021 / PRNewswire / -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory
Displaying 1 - 10 of 20